By Dr Matt Clifford and Dr Will Ormiston, Interventional Radiologists, Nedlands
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms (LUTS) in older men, significantly impacting quality of life.
While pharmacotherapy and surgical options such as transurethral resection of the prostate (TURP) remain mainstays of treatment, a growing cohort of patients are now turning toward minimally invasive, lower risk therapies that preserve sexual function and reduce recovery time.
Prostate artery embolisation (PAE) has emerged as an endovascular alternative. With mounting high-level evidence, including multiple randomised controlled trials and long-term follow-up studies,...
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms (LUTS) in older men, significantly impacting quality of life.
While pharmacotherapy and surgical options such as transurethral resection of the prostate (TURP) remain mainstays of treatment, a growing cohort of patients are now turning toward minimally invasive, lower risk therapies that preserve sexual function and reduce recovery time.
Prostate artery embolisation (PAE) has emerged as an endovascular alternative. With mounting high-level evidence, including multiple randomised controlled trials and long-term follow-up studies,...
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.